{"public_id":"co_e06238608b5466df275cde4004656bf8","status":"active","merged_into_public_id":null,"resolved_public_id":"co_e06238608b5466df275cde4004656bf8","name":"TIMP-2","description":"A tissue inhibitor of metalloproteinases examined here for a novel role in suppressing tyrosine kinase-type growth factor receptor signaling independently of MMP inhibitory activity.","aliases":["tissue inhibitor of metalloproteinases-2"],"types":["protein","signaling regulator"],"contributors":[{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["extraction"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":39982271,"title":"Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Suppresses TKR-Growth Factor Signaling Independent of Metalloproteinase Inhibition*","citation_count":128,"url":"https://sah.borca.ai/papers/39982271"}],"claims":[{"public_id":"cl_4bac31bd924a4f9ad66fffa952a88688","text":"TIMP-2 induces decreased phosphorylation of EGFR and a concomitant reduction in Grb-2 association.","corpus_id":39982271,"url":"https://sah.borca.ai/claims/cl_4bac31bd924a4f9ad66fffa952a88688"},{"public_id":"cl_5312c92be8ebc79137951e215014f031","text":"TIMP-2 suppression of mitogenesis is reversed by the adenylate cyclase inhibitor SQ22536, implicating cAMP as the second messenger in these effects.","corpus_id":39982271,"url":"https://sah.borca.ai/claims/cl_5312c92be8ebc79137951e215014f031"},{"public_id":"cl_c0b871d753603948e1e5d90f65e4e41b","text":"TIMP-2 suppresses the mitogenic response to tyrosine kinase-type growth factor receptors in a manner independent of matrix metalloproteinase inhibition.","corpus_id":39982271,"url":"https://sah.borca.ai/claims/cl_c0b871d753603948e1e5d90f65e4e41b"},{"public_id":"cl_d2d7847d51011e0c8dbd277ef6db8aca","text":"TIMP-2 prevents SHP-1 dissociation from the immunoprecipitable EGFR complex and selectively increases total SHP-1 activity.","corpus_id":39982271,"url":"https://sah.borca.ai/claims/cl_d2d7847d51011e0c8dbd277ef6db8aca"},{"public_id":"cl_d5cba815614b2f3aee0b20e1469d2b48","text":"TIMP-2 binds specifically and saturably to A549 cell surfaces with a Kd of 147 pM, independently of MT-1-MMP and not competed by the synthetic MMP inhibitor BB-94.","corpus_id":39982271,"url":"https://sah.borca.ai/claims/cl_d5cba815614b2f3aee0b20e1469d2b48"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_e06238608b5466df275cde4004656bf8","url":"https://sah.borca.ai/concepts/co_e06238608b5466df275cde4004656bf8"}